Cellinta

Curated by Signal

Developer of stem cell-based gene therapy for cancer treatment

Overview

Cellinta is a developer of stem cell-based gene therapy for cancer treatment. It has developed computational tools and patient-derived cancer stem cell models to identify, screen, and regulatory circuits that can identify cancer stem cell-specific regulatory circuits.

Key facts

Founded: 2019
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

OnCare
Provider of care management platform for elder care professionals and agencies
Health TechnologyLondon, United Kingdom
WeConnect Care
Digital medicine management tool for providers
Health TechnologyUnited Kingdom
TRACS
Cloud-based maternity care solutions for working women
Health TechnologyWinchester, United Kingdom

About Cellinta

What does Cellinta do?

Cellinta is a developer of stem cell-based gene therapy for cancer treatment.

Where is Cellinta headquartered?

Cellinta is headquartered in London, United Kingdom.

When was Cellinta founded?

Cellinta was founded in 2019.

Which sector is Cellinta in?

Cellinta operates in Health Technology.

Who are Cellinta's competitors?

Companies similar to Cellinta include OnCare, WeConnect Care, and TRACS.